Table of Contents
Volume 2012, Article ID 536396, 6 pages
Research Article

Modulation of Lipoprotein Cholesterol Levels in Plasmodium berghei Malarial Infection by Crude Aqueous Extract of Ganoderma lucidum

1Department of Biochemistry, College of Natural Science, Joseph Ayo Babalola University, Ikeji-Arakeji, Osun, Nigeria
2Department of Biochemistry, Faculty of Science, Adekunle Ajasin University, Akungba Akoko, Ondo , Nigeria
3Department of Medical Biochemistry, College of Medicine, Ambrose Alli University, Ekpoma, Nigeria
4Department of Biochemistry, Faculty of Life Sciences, University of Benin, Benin, Nigeria

Received 5 April 2012; Revised 12 June 2012; Accepted 18 June 2012

Academic Editor: Gerhard M. Kostner

Copyright © 2012 Olarewaju M. Oluba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. J. Vial, M. J. Thuet, and J. R. Philippot, “Phospholipid biosynthesis in synchronous Plasmodium falciparum cultures,” Journal of Protozoology, vol. 29, no. 2, pp. 258–263, 1982. View at Google Scholar · View at Scopus
  2. P. Grellier, D. Rigomier, V. Clavey, J. C. Fruchart, and J. Schrevel, “Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells,” Journal of Cell Biology, vol. 112, no. 2, pp. 267–277, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Krishnegowda and D. C. Gowda, “Intraerythrocytic Plasmodium falciparum incorporates extraneous fatty acids to its lipids without any structural modification,” Molecular and Biochemical Parasitology, vol. 132, no. 1, pp. 55–58, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. V. O. Ofulla, V. C. N. Okoye, B. Khan et al., “Cultivation of Plasmodium falciparum parasites in a serum-free medium,” American Journal of Tropical Medicine and Hygiene, vol. 49, no. 3, pp. 335–340, 1993. View at Google Scholar · View at Scopus
  5. G. N. Moll, H. J. Vial, M. L. Ancelin, J. A. F. Op den Kamp, B. Roelofsen, and L. L. M. Van Deenen, “Phospholipid uptake by Plasmodium knowlesi infected erythrocytes,” FEBS Letters, vol. 232, no. 2, pp. 341–346, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Mi-Ichi, K. Kita, and T. Mitamura, “Intraerythrocytic Plasmodium falciparum utilize a broad range of serum-derived fatty acids with limited modification for their growth,” Parasitology, vol. 133, no. 4, pp. 399–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. N. M. Q. Palacpac, Y. Hiramine, F. Mi-Ichi et al., “Developmental-stage-specific triacylglycerol biosynthesis, degradation and trafficking as lipid bodies in Plasmodium falciparum-infected erythrocytes,” Journal of Cell Science, vol. 117, no. 8, pp. 1469–1480, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. N. Lombard, R. Bazin, G. Durand et al., “Rodent Plasmodium development in livers of genetically obese Zucker rats (fa/fa),” European Journal of Protistology, vol. 34, no. 1, pp. 78–81, 1998. View at Google Scholar · View at Scopus
  9. P. Gratraud, E. Huws, B. Falkard et al., “Oleic acid biosynthesis in Plasmodium falciparum: characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target,” PloS ONE, vol. 4, no. 9, article e6889, 2008. View at Google Scholar · View at Scopus
  10. A. T. Borchers, J. S. Stern, R. M. Hackman, C. L. Keen, and M. E. Gershwin, “Mushrooms, tumors, and immunity,” Proceedings of the Society for Experimental Biology and Medicine, vol. 221, no. 4, pp. 281–293, 1999. View at Google Scholar · View at Scopus
  11. Y. Kabir, S. Kimura, and T. Tamura, “Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR),” Journal of Nutritional Science and Vitaminology, vol. 34, no. 4, pp. 433–438, 1988. View at Google Scholar · View at Scopus
  12. R. Li Khva, A. V. Vasil'ev, A. N. Orekhov, V. V. Tertov, and V. A. Tutel'ian, “Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation),” Voprosy Pitaniia, vol. 1, pp. 16–19, 1989. View at Google Scholar · View at Scopus
  13. P. C. K. Cheung and M. Y. Lee, “Fractionation and characterization of mushroom dietary fiber (nonstarch polysaccharides) as potential nutraceuticals from sclerotia of Pleurotus tuber-regium (fries) singer,” Journal of Agricultural and Food Chemistry, vol. 48, no. 8, pp. 3148–3151, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Fukushima, M. Nakano, Y. Morii, T. Ohashi, Y. Fujiwara, and K. Sonoyama, “Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber,” Journal of Nutrition, vol. 130, no. 9, pp. 2151–2156, 2000. View at Google Scholar · View at Scopus
  15. J. Tao and K. Feng, “Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation,” Journal of Tongji Medical University, vol. 10, no. 4, pp. 240–243, 1990. View at Google Scholar · View at Scopus
  16. S. T. Chang, “Ganoderma-the leader in production and technology of mushroom neutraceuticals,” in Recent Advances in Ganoderma lucidum Research, B. K. Kim and Y. S. Kim, Eds., pp. 43–52, The Pharmaceutical Society of Korea, Seoul, Korea, 1995. View at Google Scholar
  17. A. W. Chen and P. G. Miles, “Biomedical research and the application of the mushroom nutriceuticals from Ganoderma lucidum,” in Mushroom Biology and Mushroom Products, D. J. Royse, Ed., pp. 161–175, The Pennsylvania State University, University Park, Pa, USA, 1996. View at Google Scholar
  18. S. T. Chang and J. A. Buswell, “Medicinal Mushrooms—a prominent source of nutriceuticals for the 21st century,” Current Topics in Nutraceutical Research, vol. 1, pp. 257–280, 2003. View at Google Scholar
  19. O. M. Oluba, E. C. Onyeneke, G. C. Ojieh, B. O. Idonije, and T. I. Ojiezeh, “Hepatoprotective potential of aqueous extract of Ganoderma lucidum against carbon tetrachloride intoxication in rats,” Der Pharmacia Lettre, vol. 2, no. 4, pp. 432–439, 2010. View at Google Scholar
  20. National Research Council, Guides For the Care and Use of Laboratory Animals, National Institutes of Health, Bethesda, Md, USA, 1985.
  21. L. H. Carvalho, M. G. L. Brandao, D. Santos-Filho, J. L. C. Lopes, and A. U. Krettli, “Antimalarial activity of crude extracts from Brazilian plants studied in vivo in Plasmodium berghei-infected mice and in vitro against Plasmodium falciparum in culture,” Brazilian Journal of Medical and Biological Research, vol. 24, no. 11, pp. 1113–1123, 1991. View at Google Scholar · View at Scopus
  22. M. I. Builders, N. N. Wannang, G. A. Ajoku, P. F. Builders, A. Onsadipe, and J. C. Aguiyi, “Evaluation of the antimalarial potential of Vernonia ambigua kotschy and peyr (Asteraceae),” International Journal of Pharmacology, vol. 7, no. 2, pp. 238–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Beckwith, R. H. Schenkel, and P. H. Silverman, “Qualitative analysis of phospholipids isolated from nonviable Plasmodium antigen,” Experimental Parasitology, vol. 37, no. 2, pp. 164–172, 1975. View at Google Scholar · View at Scopus
  24. D. H. Beach, I. W. Sherman, and G. G. Holz, “Lipids of Plasmodium lophurae, and of erythrocytes and plasmas of normal and P. lophurae infected Pekin ducklings,” Journal of Parasitology, vol. 63, no. 1, pp. 62–75, 1977. View at Google Scholar · View at Scopus
  25. G. C. Akuodor, M. Idris-Usman, T. C. Ugwu, J. L. Akpan, S. I. Ghasi, and U. A. Osunkwo, “In vivo schizonticidal activity of ethanolic leaf extract of Ganoderma latifolium on Plasmodium berghei berghei in mice,” African Journal of Biotechnology, vol. 9, no. 5, pp. 2316–2321, 2010. View at Google Scholar
  26. S. Dewanjee, A. Maiti, M. Kundu, and S. G. Mandal, “Evaluation of anthelmintic activity of crude extracts of Diospyros peregrina, Coccinia grandis and Schima wallichii,” Dhaka University Journal of Pharmaceutical Sciences, vol. 6, no. 2, pp. 121–123, 2007. View at Google Scholar · View at Scopus
  27. J. D. Philipson and C. W. Wright, “Antiprotozoal compounds from plants source,” Planta Medica, vol. 57, pp. 553–559, 1990. View at Google Scholar
  28. W. Milliken, “Malaria and antimalarial plants in Roraima, Brazil,” Tropical Doctor, vol. 27, no. 1, pp. 20–25, 1997. View at Google Scholar · View at Scopus
  29. S. B. Christensen and A. Kharazmi, “Antimalarial natural products: isolation, characterization and biological properties,” in Bioactive Compounds From Natural Sources, Tringali, Ed., pp. 379–432, Taylor & Francis, London, UK, 2001. View at Google Scholar
  30. E. C. Onyeneke, E. O. Alumanah, and F. E. Mba, “Serum lipoprotein cholesterol of malarial patients: possible effects of chloroquine administration,” Journal of Environmental Toxicology, vol. 1, pp. 15–21, 1997. View at Google Scholar
  31. I. C. Onongbu and E. C. Onyeneke, “Plasma lipid changes in human malaria,” Tropenmedizin und Parasitologie, vol. 34, no. 3, pp. 193–196, 1983. View at Google Scholar · View at Scopus
  32. C. Seshadri, B. R. Shetty, N. Gowri et al., “Biochemical changes at different levels of parasitaemia in Plasmodium vivax malaria,” Indian Journal of Medical Research, vol. 77, no. 4, pp. 437–442, 1983. View at Google Scholar · View at Scopus
  33. P. Maurois, P. Charet, A. Nouvelot, J. C. Fruchart, A. Vernes, and J. Biguet, “Kinetic study of serum lipoproteins, total cholesterol and triacylglycerides in various models of experimental rodent malaria,” Annals of Tropical Medicine and Parasitology, vol. 74, no. 1, pp. 17–28, 1980. View at Google Scholar · View at Scopus